Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deininger

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Frontiers in Medicine|July 10, 2023
Recommendations on the structure, personal, and organization of intensive care unitsChristian Waydhas, Reimer Riessen, Andreas Markewitz, et al.
Leukemia|April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibA Hochhaus, M Baccarani, M Deininger, et al.
Bone Marrow Transplantation|September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimensM Deininger, W Pönisch, R Krahl, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Leukemia|September 13, 2003
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, O G Ottmann, M Deininger, et al.
Frontiers in Medicine|July 10, 2023
Recommendations on the structure, personal, and organization of intensive care unitsChristian Waydhas, Reimer Riessen, Andreas Markewitz, et al.
Leukemia|April 11, 2008
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinibA Hochhaus, M Baccarani, M Deininger, et al.
Bone Marrow Transplantation|September 12, 2001
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimensM Deininger, W Pönisch, R Krahl, et al.
Pageof 5